Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
2011

Identifying Cancer Drugs Using Gene-Signature Mapping

Sample size: 64 publication 10 minutes Evidence: moderate

Author Information

Author(s): Darragh G. McArt, Shu-Dong Zhang

Primary Institution: Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast

Hypothesis

Can gene-signature perturbation improve the identification of candidate small-molecule therapeutics for cancer?

Conclusion

The gene-signature perturbation approach enhances the specificity and reliability of identifying potential therapeutic candidates for various cancers.

Supporting Evidence

  • The perturbation method identified meaningful biological connections suggesting relevant candidate drugs for AML, cervical cancer, and breast cancer.
  • In AML, retinoic acids and PPAR activators were identified as prevalent compounds.
  • For cervical cancer, drugs involving the EGFR pathway were suggested.
  • In breast cancer, candidates involved in prostaglandin inhibition were identified.

Takeaway

Researchers used a new method to find drugs that might help treat different types of cancer by looking at how genes behave. This method helps them find better drug options.

Methodology

The study applied gene-signature perturbation to three datasets from the GEO database to identify candidate drugs for acute myeloid leukemia, cervical cancer, and breast cancer.

Potential Biases

Potential biases may arise from the selection of datasets and the inherent variability in gene expression profiles.

Limitations

The study's findings are based on specific datasets and may not generalize to all cancer types.

Participant Demographics

The study included samples from healthy donors and patients with acute myeloid leukemia, cervical cancer, and breast cancer.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016382

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication